[Federal Register Volume 89, Number 185 (Tuesday, September 24, 2024)]
[Notices]
[Page 77874]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21838]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the NIH Clinical Center 
Research Hospital Board.
    This will be a hybrid meeting held in-person and virtually and will 
be open to the public as indicated below. Individuals who plan to 
attend in-person or view the virtual meeting and need special 
assistance or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting. The meeting can 
be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/.

    Name of Committee: NIH Clinical Center Research Hospital Board.
    Date: October 18, 2024.
    Time: 9:00 a.m. to 1:00 p.m.
    Agenda: NIH and Clinical Center (CC) Leadership Announcements, 
CC CEO Update of Recent Activities and Organizational Priorities, 
Status Report on Key CC Strategic Plan Initiatives, and Other 
Business of the Clinical Center Research Hospital Board (CCRHB).
    Place: National Institutes of Health, Building 31, Conference 
Room 6C02 A & B, 9000 Rockville Pike, Bethesda, MD 20892 (In-Person 
and Virtual)
    Contact Persons:
    Patricia Piringer, RN, MSN (C), National Institutes of Health 
Clinical Center, 10 Center Drive, Bethesda, MD 20892 
[email protected], (301) 402-2435, (202) 460-7542 (direct).
    Natascha Pointer, Management Analyst, Executive Assistant to Dr. 
Gilman Office of the Chief Executive Officer, National Institutes of 
Health Clinical Center, 10 Center Drive, Bethesda, MD 20892, 
[email protected], (301) 496-4114, (301) 402-2434 (direct).

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person(s) 
listed on this notice. The statement should include the name, 
address, telephone number and, when applicable, the business or 
professional affiliation of the interested person.
    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Information is also available on the CCRHB website: https://www.ccrhb.od.nih.gov/ where an agenda and any additional information 
for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: September 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-21838 Filed 9-23-24; 8:45 am]
BILLING CODE 4140-01-P